Martin Warman
University of Strathclyde
Professor of Practice
Martin is Director of Martin Warman Consultancy Ltd and a Professor of Practice at University of Strathclyde.
He spent 7 years at Vertex, developing the Vertex continuous manufacturing (CM) platform, on which the first approved CM products are manufactured.
He has over 25 years’ experience in the field having previously led the Global PAT Development Team, Pfizer Global Manufacturing
Martin plays an active role in ASTM E55, being the technical lead on standards covering sampling, PAT enabled control systems and continuous manufacturing, is on the ISPE PAT Community of Practice (CoP) global steering committee, and chairs the UK Affiliate PAT CoP.
Part of this role at University of Strathclyde includes supporting the Centre for Process Analytics and Control Technology (CPACT) and CMAC Future Manufacturing Research Hub as well as being the Research Director for the new Medicines Manufacturing Innovation Centre (MMIC) being built in Renfrewshire, Scotland.
He spent 7 years at Vertex, developing the Vertex continuous manufacturing (CM) platform, on which the first approved CM products are manufactured.
He has over 25 years’ experience in the field having previously led the Global PAT Development Team, Pfizer Global Manufacturing
Martin plays an active role in ASTM E55, being the technical lead on standards covering sampling, PAT enabled control systems and continuous manufacturing, is on the ISPE PAT Community of Practice (CoP) global steering committee, and chairs the UK Affiliate PAT CoP.
Part of this role at University of Strathclyde includes supporting the Centre for Process Analytics and Control Technology (CPACT) and CMAC Future Manufacturing Research Hub as well as being the Research Director for the new Medicines Manufacturing Innovation Centre (MMIC) being built in Renfrewshire, Scotland.